1
|
Zhang M, Liu CF, Chen XY, Yang LN, Zhu CM, Teng JH, Wu HX, Zhang FL. Effect of Oxygen and Water on the Stability of Imipenem and Cilastatin Sodium for Injection. Pharmaceutical Fronts 2022. [DOI: 10.1055/s-0042-1750043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
Abstract
AbstractThe study aimed to investigate the factors affecting the stability of imipenem and cilastatin sodium for injection (IMI/CIL) to improve the quality and stability in IMI/CIL preparation. In this study, the effects of headspace oxygen (HO), water content, particle shape, and particle size on the stability of IMI/CIL were investigated. IMI/CIL was purged with air, premixed oxygen/nitrogen gas (5%/95%), or high-purity nitrogen (99.999%) at 20, 5, or 2% oxygen levels to prepare IMI/CIL with different HO levels. IMI/CIL was stored at 30, 45, and 75% relative humidity for 30 days to prepare IMI/CIL with different water contents. High-performance liquid chromatography method was used for analysis. The results showed that oxygen, water, particle shape, and particle size had significant effects on the stability of IMI/CIL, and free water content is a better predictor of the safety and stability of imipenem and cilastatin sodium than the total water content. The optimization scheme of the above parameters is proposed, which significantly improves the stability of IMI/CIL. This study led to a better understanding of the degradation mechanism of imipenem and cilastatin sodium, and could provide a reference for the selection and control of IMI/CIL process conditions. This study would contribute to the development of IMI/CIL with improved stability.
Collapse
Affiliation(s)
- Meng Zhang
- College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
| | - Chun-Feng Liu
- Pharmaceutical Process Optimization and Industrialization Engineering Research Center, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
| | - Xiao-Yan Chen
- China National Medicines Guorui Pharmaceutical Co., Ltd., Huainan, People's Republic of China
| | - Li-Na Yang
- Pharmaceutical Process Optimization and Industrialization Engineering Research Center, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
| | - Chun-Mei Zhu
- Pharmaceutical Process Optimization and Industrialization Engineering Research Center, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
| | - Jian-Hao Teng
- Pharmaceutical Process Optimization and Industrialization Engineering Research Center, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
| | - Hao-Xiang Wu
- Pharmaceutical Process Optimization and Industrialization Engineering Research Center, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
| | - Fu-Li Zhang
- College of Chemistry and Chemical Engineering, Shanghai University of Engineering Science, Shanghai, People's Republic of China
- Pharmaceutical Process Optimization and Industrialization Engineering Research Center, Shanghai Institute of Pharmaceutical Industry, China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China
| |
Collapse
|
2
|
Gabrič A, Hodnik Ž, Pajk S. Oxidation of Drugs during Drug Product Development: Problems and Solutions. Pharmaceutics 2022; 14:pharmaceutics14020325. [PMID: 35214057 PMCID: PMC8876153 DOI: 10.3390/pharmaceutics14020325] [Citation(s) in RCA: 18] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2021] [Revised: 01/17/2022] [Accepted: 01/21/2022] [Indexed: 11/16/2022] Open
Abstract
Oxidation is the second most common degradation pathway for pharmaceuticals, after hydrolysis. However, in contrast to hydrolysis, oxidation is mechanistically more complex and produces a wider range of degradation products; oxidation is thus harder to control. The propensity of a drug towards oxidation is established during forced degradation studies. However, a more realistic insight into degradation in the solid state can be achieved with accelerated studies of mixtures of drugs and excipients, as the excipients are the most common sources of impurities that have the potential to initiate oxidation of a solid drug product. Based on the results of these studies, critical parameters can be identified and appropriate measures can be taken to avoid the problems that oxidation poses to the quality of a drug product. This article reviews the most common types of oxidation mechanisms, possible sources of reactive oxygen species, and how to minimize the oxidation of a solid drug product based on a well-planned accelerated study.
Collapse
Affiliation(s)
- Alen Gabrič
- Krka d.d., R&D, Šmarješka Cesta 6, 8001 Novo Mesto, Slovenia;
- Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia
| | - Žiga Hodnik
- Krka d.d., R&D, Šmarješka Cesta 6, 8001 Novo Mesto, Slovenia;
- Correspondence: (Ž.H.); (S.P.)
| | - Stane Pajk
- Faculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia
- Correspondence: (Ž.H.); (S.P.)
| |
Collapse
|
3
|
Campbell MTD, Jones DS, Andrews GP, Li S. Understanding the physicochemical properties and degradation kinetics of nicotinamide riboside, a promising vitamin B 3nutritional supplement. Food Nutr Res 2019; 63:3419. [PMID: 31807125 PMCID: PMC6878970 DOI: 10.29219/fnr.v63.3419] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2019] [Revised: 09/11/2019] [Accepted: 10/16/2019] [Indexed: 11/20/2022] Open
Abstract
Nicotinamide riboside (NR), a newly recognised form of vitamin B3 and a precursor to nicotinamide adenine dinucleotide (NAD+), has been demonstrated to show therapeutic potential and the possibility of becoming a drug compound in addition to its proven role in rejuvenating ageing cells in mice. However, current literature is devoid of information relating to the physicochemical characterisation of NR and its respective impact upon formulation and final product processing. Here we report physicochemical properties of NR including pKa, log P, solubility, melting point, degradation mechanics, and kinetics, with a special focus on its stability under thermal and physiologically relevant conditions. A simple and rapid HPLC method confirms a base-catalysed hydrolysis degradation of NRCl to nicotinamide and sugar in simulated gastrointestinal (GI) fluids. Given the antagonising effect of nicotinamide against NR, the presented data have a profound impact on how NRCl should be handled both during formulation and storage to prevent formation and to limit accumulation of nicotinamide. The innovative combinatorial use of 1H NMR and Differential Scanning Calorimetry (DSC) was employed to investigate thermal events during NR melting. NRCl degrades upon melting and in solution undergoes hydrolysis in a buffer and in simulated intestinal environments. The results suggest that a proper and evidence-based formulation of NRCl is vital to enable further investigation and clinical analysis of this promising and novel nutrient. Any formulation would need to promote the stability of NRCl and protect it from hostile environments to prevent the accumulation of a potentially antagonistic degradation product. With the current work, we have filled a niche but vital gap in NR literature and the data presented may prove useful in furthering the understanding, specifically the formulation and processing of NRCl.
Collapse
Affiliation(s)
| | - David S Jones
- School of Pharmacy, Queens University Belfast, Belfast, Norther Ireland, UK
| | - Gavin P Andrews
- School of Pharmacy, Queens University Belfast, Belfast, Norther Ireland, UK
| | - Shu Li
- School of Pharmacy, Queens University Belfast, Belfast, Norther Ireland, UK
| |
Collapse
|
4
|
Feng J, Zhana X, Qiaob S, Wub C, Xiaob L. A mathematical model for calculating the shelf life of ascorbic acid solution under given conditions. Drug Dev Ind Pharm 2011; 38:264-70. [PMID: 21812540 DOI: 10.3109/03639045.2011.598537] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The objective of this paper is to calculate the shelf life of ascorbic acid solution under given conditions by using a mathematical model. An antioxidant, sodium metabisulfite, was added to the ascorbic acid solution. The kinetic parameters of the degradation reaction of ascorbic acid and sodium metabisulfite, were investigated, respectively, and then a mathematical model was developed. According to the mathematical model, the calculated shelf lives of ascorbic acid solution were 783, 835, 873, and 885 days for specifications 2, 5, 10, and 20 mL, respectively. The results showed that the obtained mathematical model can be used to calculate the shelf life of ascorbic acid solution under given conditions.
Collapse
Affiliation(s)
- Jiafu Feng
- Leshan Vocational & Technical college, Leshan, Sichuan, PR China.
| | | | | | | | | |
Collapse
|